Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|13|3|236-243

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.13, Iss.3, 2017-07, pp. : 236-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase as a therapeutic target

By Kruczynski Anna   Delsol Georges   Laurent Camille   Brousset Pierre   Lamant Laurence  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of anaplastic lymphoma kinase: a patent review

By Milkiewicz Karen L   Ott Gregory R  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1653-1681

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review

By Mesaros Eugen F   Ott Gregory R   Dorsey Bruce D  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 417-442

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 17, Iss. 6, 2016-05 ,pp. : 739-745

Bentham Science Publishers

Access to resources Recommend Favorite